Skip to main content

Animations

MJFF Publications

8931 - 8940 of 9156 Results
Title
Year
  • Year
  • 2023
  • 2024
  • 2023
  • 2021
  • 2021
  • 2021
  • 2023
  • 2023
  • 2021
  • 2024
  • Summary Details
    OPEN
    Title: Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA‐PD Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1002/mds.29611
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Decreasing the intrinsically disordered protein α-synuclein levels by targeting its structured mRNA with a ribonuclease-targeting chimera
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2306682120
    Citation Count: 44
  • Summary Details
    OPEN
    Title: Characterizing expression changes in noncoding RNAs during aging and heterochronic parabiosis across mouse tissues
    Journal Name: Nature Biotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41587-023-01751-6
    Citation Count: 63
  • Summary Details
    OPEN
    Title: S-nitrosylated TDP-43 triggers aggregation, cell-to-cell spread, and neurotoxicity in hiPSCs and in vivo models of ALS/FTD
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.2021368118
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00172-z
    Citation Count: 26
  • Summary Details
    OPEN
    Title: PDKit: A data science toolkit for the digital assessment of Parkinson’s Disease
    Journal Name: PLOS Computational Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pcbi.1008833
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Association of cardiovascular disease management drugs with Lewy body dementia: a case–control study
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcad346
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Comparative analysis of methods to reduce activation signature gene expression in PBMCs
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-49611-2
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Olfactory impairment in Wilson’s disease
    Journal Name: Brain and Behavior
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/brb3.2022
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-023-00687-4
    Citation Count: 54
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.